← Eichor
Condition: Hypophosphatasia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hypophosphatasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Prospective Sub-Study of the Global Hypophosphatasia Registry
Phase N/A · 12 location(s) · Alexion Pharmaceuticals, Inc. · NCT05234567
Natural History Study of Patients With Hypophosphatasia (HPP)
Phase N/A · 1 location(s) · Duke University · NCT02237625
Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)
Phase N/A · 11 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05596539
The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia
Phase N/A · 4 location(s) · AstraZeneca · NCT07390240
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With
Phase 1/Phase 2 · 2 location(s) · Alesta Therapeutics · NCT07179640
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-
Phase N/A · 1 location(s) · University of Bonn · NCT06574282
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.